Sales in 2022 were KRW 10,705 million, with operating profit of KRW 1,777 million and net profit of KRW 880 million. In 2023, sales fell to KRW 5,402 million and the company swung to an operating loss of KRW 452 million and a net loss of KRW 611 million.
Sales in 2024 were KRW 5,488 million, roughly flat, but the operating loss widened to KRW 916 million and the net loss reached KRW 1,204 million, the largest of the three years. Sales in 2025 declined to KRW 3,749 million, with an operating loss of KRW 905 million and a net loss of KRW 831 million.
On a 2025 standalone basis, approved at the March 31, 2026 general shareholders' meeting, total assets were KRW 7,187 million, total liabilities KRW 5,184 million and total equity KRW 2,003 million, so liabilities well exceed equity.
In October 2024 the share price rose sharply over one week to KRW 7,850 on October 25, and the Korea Exchange designated the stock as a concentrated small-account trading stock that month.
Based on quotes as of October 1, 2026, the share price was KRW 2,670, market capitalization KRW 9.5 billion, the 52-week high KRW 4,885 and low KRW 2,000, with returns of -17.85% over three months, -22.50% over six months and -32.49% over twelve months. At the time of writing, the share price was KRW 3,000 and the market capitalization KRW 10.7 billion.